AI-generated summary
The authors report a single-center prospective pilot study of 20 eyes with large soft drusen and/or drusenoid pigment epithelial detachment in dry age-related macular degeneration, treated with photobiomodulation twice weekly for 5 weeks. They found a mean best-corrected visual acuity gain of 5.5 letters at 6 months, along with reductions in drusen volume and thickness, while geographic atrophy area increased. The authors describe the findings as supportive but preliminary.
- Participants
- 20
- Who or what was studied
- Twenty eyes of patients with large soft drusen and/or drusenoid pigment epithelial detachment associated with dry age-related macular degeneration
- Limits stated in the abstract
- The abstract describes a single-center pilot study with a small sample, and it reports that geographic atrophy area increased and one patient had a drusenoid pigment epithelial detachment rupture.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Age-related macular degeneration, Photobiomodulation therapy, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.